These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10436785)

  • 1. Mucin gene and antigen expression in biliopancreatic carcinogenesis.
    Kim YS; Gum JR; Crawley SC; Deng G; Ho JJ
    Ann Oncol; 1999; 10 Suppl 4():51-5. PubMed ID: 10436785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucin glycoproteins in colonic neoplasia.
    Kim YS
    Keio J Med; 1998 Mar; 47(1):10-8. PubMed ID: 9560527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin glycoproteins in neoplasia.
    Kim YS; Gum J; Brockhausen I
    Glycoconj J; 1996 Oct; 13(5):693-707. PubMed ID: 8909996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of mucin expression in pancreatobiliary neoplasms.
    Yonezawa S; Higashi M; Yamada N; Yokoyama S; Goto M
    J Hepatobiliary Pancreat Sci; 2010 Mar; 17(2):108-24. PubMed ID: 19787286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate antigens on cancer-associated mucin-like molecules.
    Ho SB; Kim YS
    Semin Cancer Biol; 1991 Dec; 2(6):389-400. PubMed ID: 1725730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered glycosylation of mucin glycoproteins in colonic neoplasia.
    Kim YS
    J Cell Biochem Suppl; 1992; 16G():91-6. PubMed ID: 1469909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucin glycoproteins as tumor markers.
    Feller WF; Henslee JG; Kinders RJ; Manderino GL; Tomita JT; Rittenhouse HG
    Immunol Ser; 1990; 53():631-72. PubMed ID: 2100576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
    Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
    Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.
    Chugh S; Gnanapragassam VS; Jain M; Rachagani S; Ponnusamy MP; Batra SK
    Biochim Biophys Acta; 2015 Dec; 1856(2):211-25. PubMed ID: 26318196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of tumor-associated epitopes on Epstein-Barr virus-immortalized B-cells and Burkitt's lymphomas transfected with epithelial mucin complementary DNA.
    Jerome KR; Bu D; Finn OJ
    Cancer Res; 1992 Nov; 52(21):5985-90. PubMed ID: 1382849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
    Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS
    Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis.
    Kasprzak A; Adamek A
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypeptide core of a human pancreatic tumor mucin antigen.
    Lan MS; Hollingsworth MA; Metzgar RS
    Cancer Res; 1990 May; 50(10):2997-3001. PubMed ID: 2334903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mucin-associated antigens as markers of gastrointestinal differentiation and carcinogenesis].
    Baldus SE; Hanisch FG
    Pathologe; 1995 Mar; 16(2):94-105. PubMed ID: 7539132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid.
    Devine PL; Clark BA; Birrell GW; Layton GT; Ward BG; Alewood PF; McKenzie IF
    Cancer Res; 1991 Nov; 51(21):5826-36. PubMed ID: 1718585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing epitopes consisting of sialyl or sialyl-fucosyl type 1 chain.
    Kannagi R; Kitahara A; Itai S; Zenita K; Shigeta K; Tachikawa T; Noda A; Hirano H; Abe M; Shin S
    Cancer Res; 1988 Jul; 48(13):3856-63. PubMed ID: 2454154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and localization of MUC1, MUC2, MUC5AC and small intestinal mucin antigen in pancreatic tumors.
    Yamasaki H; Ikeda S; Okajima M; Miura Y; Asahara T; Kohno N; Shimamoto F
    Int J Oncol; 2004 Jan; 24(1):107-13. PubMed ID: 14654947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.
    Jerome KR; Domenech N; Finn OJ
    J Immunol; 1993 Aug; 151(3):1654-62. PubMed ID: 8393050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product.
    Burchell J; Taylor-Papadimitriou J
    Epithelial Cell Biol; 1993 Oct; 2(4):155-62. PubMed ID: 7505698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.